Assessment of the Effects of Age and Renal Function on Pharmacokinetics of Bazedoxifene in Postmenopausal Women

Clinical Pharmacology in Drug Development
William McKeandJ Korth-Bradley

Abstract

Bazedoxifene (BZA), a chemically distinct selective estrogen receptor modulator, has demonstrated efficacy and long-term safety in phase 3 placebo-controlled studies for prevention and treatment of osteoporosis. Here, we assessed the potential effects of age and renal function on BZA pharmacokinetics in healthy postmenopausal women (aged 55-84 years; CLcr, 32-109 mL/min). This was an open-label, single-dose, parallel, nonrandomized inpatient study conducted in healthy postmenopausal women and postmenopausal women with impaired renal function. Each subject received a single oral dose of BZA in a 20-mg tablet. Twenty-six subjects were enrolled: 8 in each of 3 age groups (55-64 years, 65-74 years, ≥75 years) and 2 (aged 71 and 75 years) with mild renal impairment; all subjects received treatment and completed the study. Age-related changes in pharmacokinetics were apparent. Although the correlation was modest (R2 = 0.28), BZA CL/F decreased steadily with age, such that the oldest group (>75 years) had a mean CL/F 60% less than the youngest group (55-64 years). Over the observed range of CLcr, there was a weak positive correlation (R2 = 0.19) between BZA CL/F and CLcr.

References

Feb 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H A WynneO F James
Sep 1, 1988·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G MarchesiniE Pisi
May 6, 1982·The New England Journal of Medicine·D J GreenblattR I Shader
Apr 1, 1996·Clinical Pharmacology and Therapeutics·F PeyradeG Milano
Dec 13, 2007·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Paul D MillerPierre D Delmas
Jul 31, 2008·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Stuart L SilvermanArkadi A Chines
Mar 11, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Appavu ChandrasekaranJoAnn Scatina
Jun 24, 2009·Menopause : the Journal of the North American Menopause Society·JoAnn V PinkertonGinger D Constantine
Jun 24, 2009·Menopause : the Journal of the North American Menopause Society·JoAnn V PinkertonJames H Pickar
Jan 9, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Christian AymannsDavid Czock
Jun 3, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Li ShenAppavu Chandrasekaran
Feb 4, 2011·Menopause : the Journal of the North American Menopause Society·Gloria BachmannGinger D Constantine
Jan 21, 2014·The Journal of Clinical Endocrinology and Metabolism·Joann V PinkertonUNKNOWN SMART-5 Investigators
Feb 11, 2015·Menopause : the Journal of the North American Menopause Society·Santiago PalaciosUNKNOWN Bazedoxifene Study Group
Jul 1, 2014·Clinical Pharmacology in Drug Development·William E McKeandArkadi A Chines
Feb 2, 2018·Clinical Pharmacology in Drug Development·William McKeandAlain Patat
Feb 15, 2018·Clinical Pharmacology in Drug Development·William McKeandAlain Patat
Apr 24, 2018·Clinical Pharmacology in Drug Development·William McKeandAlain Patat

❮ Previous
Next ❯

Citations

May 16, 2019·Expert Opinion on Pharmacotherapy·Maria P YavropoulouAthanasios D Anastasilakis
Jan 1, 2022·Experimental and Therapeutic Medicine·Qian YuBaotang Liu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.